These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 15835076)

  • 1. Age-specific incidence and clearance of high-risk human papillomavirus infections in women in the former Soviet Union.
    Syrjänen S; Shabalova I; Petrovichev N; Podistov J; Ivanchenko O; Zakharenko S; Nerovjna R; Kljukina L; Branovskaja M; Juschenko A; Tosi P; Syrjänen K;
    Int J STD AIDS; 2005 Mar; 16(3):217-23. PubMed ID: 15835076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
    Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
    J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study.
    Goodman MT; Shvetsov YB; McDuffie K; Wilkens LR; Zhu X; Thompson PJ; Ning L; Killeen J; Kamemoto L; Hernandez BY
    Cancer Res; 2008 Nov; 68(21):8813-24. PubMed ID: 18974124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clearance of oral high-risk human papillomavirus infection is impaired by long-term persistence of cervical human papillomavirus infection.
    Louvanto K; Rautava J; Syrjänen K; Grénman S; Syrjänen S
    Clin Microbiol Infect; 2014 Nov; 20(11):1167-72. PubMed ID: 24890849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological data of different human papillomavirus genotypes in cervical specimens of HIV-1-infected women without history of cervical pathology.
    Videla S; Darwich L; Cañadas MP; Paredes R; Tarrats A; Castella E; Llatjos M; Bofill M; Clotet B; Sirera G;
    J Acquir Immune Defic Syndr; 2009 Feb; 50(2):168-75. PubMed ID: 19131892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and duration of cervical human papillomavirus 6, 11, 16, and 18 infections in young women: an evaluation from multiple analytic perspectives.
    Insinga RP; Dasbach EJ; Elbasha EH; Liaw KL; Barr E
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):709-15. PubMed ID: 17416761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of high-risk human papillomavirus infections and pap smear abnormalities among women in the New Independent States of the Former Soviet Union.
    Syrjänen S; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grunberga V; Grunberg A; Juschenko A; Tosi P; Cintorino M; Santopietro R; Syrjänen K
    J Clin Microbiol; 2004 Feb; 42(2):505-11. PubMed ID: 14766808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The natural history of type-specific human papillomavirus infections in female university students.
    Richardson H; Kelsall G; Tellier P; Voyer H; Abrahamowicz M; Ferenczy A; Coutlée F; Franco EL
    Cancer Epidemiol Biomarkers Prev; 2003 Jun; 12(6):485-90. PubMed ID: 12814991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre-vaccination prevalence of infections with 25 non-high-risk human papillomavirus types among 1,000 Slovenian women in cervical cancer screening.
    Učakar V; Poljak M; Oštrbenk A; Klavs I
    J Med Virol; 2014 Oct; 86(10):1772-9. PubMed ID: 24978445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors predicting persistence of high-risk human papillomavirus (HPV) infections in women prospectively followed-up in three New Independent States (NIS) of the former Soviet Union.
    Syrjänen S; Shabalova I; Petrovichev N; Kozachenko V; Zakharova T; Pajanidi J; Podistov J; Chemeris G; Sozaeva L; Lipova E; Tsidaeva I; Ivanchenko O; Pshepurko A; Zakharenko S; Nerovjna R; Kljukina L; Erokhina O; Branovskaja M; Nikitina M; Grunberga V; Grunberg A; Juschenko A; Cintorino M; Santopietro R; Tosi P; Syrjänen K
    Eur J Gynaecol Oncol; 2005; 26(5):491-8. PubMed ID: 16285563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples.
    Cibas ES; Hong X; Crum CP; Feldman S
    Gynecol Oncol; 2007 Mar; 104(3):702-6. PubMed ID: 17150245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.
    Franco EL; Villa LL; Sobrinho JP; Prado JM; Rousseau MC; Désy M; Rohan TE
    J Infect Dis; 1999 Nov; 180(5):1415-23. PubMed ID: 10515798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union.
    Kulmala SM; Shabalova IP; Petrovitchev N; Syrjänen KJ; Gyllensten UB; Syrjänen SM;
    J Med Virol; 2007 Jun; 79(6):771-81. PubMed ID: 17457909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus detection in pregnant women: a prospective matched cohort study.
    Schmeink CE; Melchers WJ; Hendriks JC; Quint WG; Massuger LF; Bekkers RL
    J Womens Health (Larchmt); 2012 Dec; 21(12):1295-301. PubMed ID: 23210493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms and predictors of high-risk human papillomavirus (HPV) clearance in the uterine cervix.
    Syrjänen K
    Eur J Gynaecol Oncol; 2007; 28(5):337-51. PubMed ID: 17966211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Spontaneous clearance of high risk human papillomavirus infection].
    Zhang WY; Ma CB; Xiao JY; Zhou HR
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jul; 45(7):515-8. PubMed ID: 21029604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical human papillomavirus screening among older women.
    Grainge MJ; Seth R; Guo L; Neal KR; Coupland C; Vryenhoef P; Johnson J; Jenkins D
    Emerg Infect Dis; 2005 Nov; 11(11):1680-5. PubMed ID: 16318718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
    Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
    Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.